A 3-member panel of judges from the U.S. Court of Appeals for the 9th Circuit expresses skepticism over a $60 million trademark infringement win for NeuroVision over NuVasive. A trio of federal judges this week expressed skepticism over a $60 million trademark infringement win NeuroVision Medical Products logged against NuVasive Inc. (NSDQ:NUVA) in 2010. NuVasive appealed the decision, arguing in March that the judge who handled the case “fundamentally misunderstood trademark law” and “exhibited hostility toward NuVasive’s counsel in front of the jury.”
